Quest Diagnostics
491 hedge funds and large institutions have $8.54B invested in Quest Diagnostics in 2014 Q1 according to their latest regulatory filings, with 83 funds opening new positions, 172 increasing their positions, 171 reducing their positions, and 39 closing their positions.
113% more first-time investments, than exits
New positions opened: 83 | Existing positions closed: 39
100% more funds holding in top 10
Funds holding in top 10: 3 → 6 (+3)
8% more funds holding
Funds holding: 455 → 491 (+36)
6% more capital invested
Capital invested by funds: $8.05B → $8.54B (+$491M)
1.35% more ownership
Funds ownership: 103.39% → 104.75% (+1.4%)
1% more repeat investments, than reductions
Existing positions increased: 172 | Existing positions reduced: 171
65% less call options, than puts
Call options by funds: $114M | Put options by funds: $325M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
+$196M |
| 2 |
FC
Fairpointe Capital
Chicago,
Illinois
|
+$139M |
| 3 |
Capital International Investors
Los Angeles,
California
|
+$119M |
| 4 |
GCM
Glenview Capital Management
New York
|
+$105M |
| 5 |
Boston Partners
Boston,
Massachusetts
|
+$89.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
-$281M |
| 2 |
Harris Associates
Chicago,
Illinois
|
-$229M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$172M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$144M |
| 5 |
Diamond Hill Capital Management
Columbus,
Ohio
|
-$96.3M |
DGX Hedge Fund Activity: Q1 2014 in Review
491 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in Quest Diagnostics (DGX) for Q1 2014, worth a combined $8.54B — up 6.1% from $8.05B a quarter earlier.
Buyers outnumbered sellers: 83 funds opened new DGX positions and 39 closed out — a net gain of 44 holders — while 172 added to existing stakes and 171 trimmed.
The largest buyer was Manulife (Manufacturers Life Insurance), adding an estimated $196M. The largest seller was Capital World Investors, cutting an estimated $281M.
- 491 institutional investors held Quest Diagnostics (DGX) as of Q1 2014, up from 455 in Q4 2013.
- Funds reported $8.54B of Quest Diagnostics stock for Q1 2014, up 6.1% quarter-over-quarter.
- 83 funds opened new Quest Diagnostics positions in Q1 2014 and 39 closed out, a net change of +44 holders.
- The largest Quest Diagnostics buyer in Q1 2014 was Manulife (Manufacturers Life Insurance), an estimated $196M added.
- The largest Quest Diagnostics seller in Q1 2014 was Capital World Investors, an estimated $281M sold.
Based on aggregated 13F filings for Q1 2014.